Telesis Bio, Inc. Common Stock
TBIO
TBIO: Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents, Coronavirus tools, and BioXp biofoundry services.
moreShow TBIO Financials
Recent trades of TBIO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TBIO's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods of cloning nucleic acids or producing proteins in a low endotoxin organism Sep. 05, 2023
-
Patent Title: Digital to biological converter Apr. 04, 2023
Federal grants, loans, and purchases
Followers on TBIO's company Twitter account
Number of mentions of TBIO in WallStreetBets Daily Discussion
Recent insights relating to TBIO
Recent picks made for TBIO stock on CNBC
ETFs with the largest estimated holdings in TBIO
Flights by private jets registered to TBIO